News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
886,118 Results
Type
Article (88975)
Company Profile (555)
Press Release (796569)
Multimedia
Podcasts (248)
Webinars (36)
Section
Business (267082)
Career Advice (4166)
Deals (40033)
Drug Delivery (182)
Drug Development (91798)
Employer Resources (208)
FDA (18610)
Job Trends (17500)
News (398930)
Policy (40026)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (4)
2027 Genetown Standard (7)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (7)
Academia (3065)
Academic (2)
Accelerated approval (60)
ADA (49)
Adcomms (43)
Allergies (211)
Alliances (56991)
ALS (246)
Alzheimer's disease (2048)
Antibody-drug conjugate (ADC) (596)
Approvals (19017)
Artificial intelligence (933)
ASCO (345)
Autoimmune disease (388)
Automation (70)
Bankruptcy (409)
Best Places to Work (12635)
BIO (79)
BIOSECURE Act (23)
Biosimilars (262)
Biotechnology (336)
Bladder cancer (219)
Brain cancer (87)
Breast cancer (867)
Cancer (6858)
Cardiovascular disease (581)
Career advice (3603)
Career pathing (54)
CAR-T (397)
CDC (77)
Celiac Disease (3)
Cell therapy (1114)
Cervical cancer (60)
Clinical research (79466)
Collaboration (2490)
Commercialization (1)
Company closure (8)
Compensation (1606)
Complete response letters (116)
COVID-19 (3046)
CRISPR (130)
C-suite (1379)
Cystic fibrosis (170)
Data (9081)
Decentralized trials (3)
Denatured (95)
Depression (207)
Dermatology (106)
Diabetes (734)
Diagnostics (7671)
Digital health (75)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (474)
Drug pricing (248)
Drug shortages (39)
Duchenne muscular dystrophy (335)
Earnings (102642)
Editorial (81)
Employer branding (25)
Employer resources (177)
Events (139077)
Executive appointments (1238)
FDA (22925)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (37)
Funding (2038)
Gene editing (285)
Generative AI (95)
Gene therapy (878)
GLP-1 (1305)
Government (5571)
Grass and pollen (8)
Guidances (427)
Healthcare (21278)
Hematology (198)
HIV (102)
Huntington's disease (73)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (121)
Immunology and inflammation (370)
Immuno-oncology (123)
Indications (229)
Infectious disease (3459)
Inflammatory bowel disease (248)
Inflation Reduction Act (17)
Influenza (156)
Intellectual property (339)
Interviews (823)
IPO (18019)
IRA (61)
Job creations (5209)
Job search strategy (2872)
JPM (73)
Kidney cancer (25)
Labor market (129)
Layoffs (698)
Leadership (55)
Legal (10172)
Liver cancer (111)
Longevity (38)
Lung cancer (906)
Lymphoma (494)
Machine learning (70)
Management (68)
Manufacturing (1321)
Marketing (7)
MASH (232)
Medical affairs (1)
Medical device (15328)
Medtech (15531)
Mergers & acquisitions (23390)
Metabolic disorders (1892)
mRNA (283)
Multiple sclerosis (214)
NASH (24)
Neurodegenerative disease (547)
Neuropsychiatric disorders (133)
Neuroscience (3888)
Neurotech (2)
NextGen: Class of 2026 (7717)
Non-profit (5149)
Now hiring (84)
Obesity (897)
Opinion (383)
Ovarian cancer (254)
Pain (297)
Pancreatic cancer (376)
Parkinson's disease (433)
Partnered (43)
Patents (699)
Patient recruitment (842)
Peanut (72)
People (68250)
Pharmaceutical (81)
Pharmacy benefit managers (38)
Phase 1 (24550)
Phase 2 (34515)
Phase 3 (25956)
Pipeline (10556)
Policy (408)
Postmarket research (3561)
Preclinical (11014)
Press Release (72)
Prostate cancer (362)
Psychedelics (79)
Radiopharmaceuticals (383)
Rare diseases (1348)
Real estate (7465)
Recruiting (82)
Regulatory (30760)
Reports (78)
Research institute (2778)
Resumes & cover letters (655)
Rett syndrome (47)
RNA editing (31)
RSV (100)
Schizophrenia (199)
Series A (347)
Series B (253)
Service/supplier (15)
Sickle cell disease (133)
Special edition (33)
Spinal muscular atrophy (192)
Sponsored (55)
Startups (4378)
State (2)
Stomach cancer (21)
Supply chain (151)
Tariffs (104)
The Weekly (150)
Vaccines (1340)
Venture capital (143)
Weight loss (608)
Women's health (148)
Worklife (25)
Date
Today (72)
Last 7 days (530)
Last 30 days (2184)
Last 365 days (33372)
2026 (18744)
2025 (33214)
2024 (37864)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1298)
Alabama (103)
Alaska (7)
Arizona (413)
Arkansas (16)
Asia (52485)
Australia (9225)
California (14813)
Canada (4164)
China (1676)
Colorado (638)
Connecticut (653)
Delaware (455)
Europe (121032)
Florida (2228)
Georgia (482)
Hawaii (4)
Idaho (70)
Illinois (1298)
India (111)
Indiana (679)
Iowa (25)
Japan (633)
Kansas (145)
Kentucky (58)
Louisiana (64)
Maine (91)
Maryland (1776)
Massachusetts (10835)
Michigan (429)
Minnesota (824)
Mississippi (7)
Missouri (168)
Montana (37)
Nebraska (31)
Nevada (160)
New Hampshire (92)
New Jersey (3925)
New Mexico (35)
New York (3910)
North Carolina (1960)
North Dakota (11)
Northern California (7402)
Ohio (462)
Oklahoma (29)
Oregon (46)
Pennsylvania (2899)
Puerto Rico (33)
Rhode Island (53)
South America (1670)
South Carolina (92)
South Dakota (2)
Southern California (5850)
Tennessee (241)
Texas (2405)
United States (52881)
Utah (444)
Vermont (2)
Virginia (370)
Washington D.C. (88)
Washington State (1203)
West Virginia (4)
Wisconsin (160)
Wyoming (2)
There are 886,118 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
India’s life sciences sector at turning point for innovation: Report
Structural gaps in areas including clinical execution and funding limit India’s ability to scale up innovation, according to a report from Boston Consulting Group and HealthKois.
July 17, 2026
·
2 min read
·
Angela Gabriel
Press Releases
IDEAYA Biosciences Announces ESMO 2026 Presentations for Darovasertib and IDE849 Clinical Programs
July 17, 2026
·
5 min read
IPO
2026 IPO stock tracker: How biotechs new to public markets are performing
BioSpace
is launching an IPO dashboard to help the industry keep tabs on U.S. biotechs that have taken the public plunge in 2026.
July 17, 2026
·
1 min read
·
Gabrielle Masson
Press Releases
Kivo Joins Experts at RAPS San Francisco to Report on Real-World AI Use Cases in Life Sciences
Seven speakers bring seven real-world AI stories to one stage, exploring how human expertise and intelligent automation are reshaping life sciences.
July 17, 2026
·
1 min read
Press Releases
Aptar Pharma Launches Integrated System-Level Framework to Support Injectable Drug Development
July 17, 2026
·
4 min read
Press Releases
ThalassaX Therapeutics Announces First Patient Dosed in U.S. Phase I Trial of CS231295, a Brain-Penetrant Aurora B Kinase Selective Inhibitor
July 17, 2026
·
2 min read
Press Releases
Veradermics Announces Presentations of Data from a Subgroup Analysis of Phase 2/3 Study ‘302’ in Males with Pattern Hair Loss at 2026 American Academy of Dermatology Innovation Academy
July 17, 2026
·
7 min read
Press Releases
Aqemia and Sanofi Expand Their Research Collaboration
July 17, 2026
·
2 min read
Press Releases
BeOne Medicines to Announce Second Quarter 2026 Financial Results on August 5
July 17, 2026
·
1 min read
Press Releases
Allergan Aesthetics receives approval for Boey® (trenibotulinumtoxinE), for use in Europe: the first and only rapid-onset, short-duration neurotoxin for the temporary improvement of frown lines in adult patients
July 17, 2026
·
11 min read
1 of 88,612
Next
